EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MXene‐Mediated Catalytic Redox Reactions for Biomedical Applications

Chenyao Wu, Lili Xia, Wei Feng, Yu Chen iD

ChemPlusChem · 2024

DOI: 10.1002/cplu.202300777 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemPlusChem, 2024. Verfasst von Chenyao Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Oxidation-Reduction. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 124 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Education Development Foundation and Shanghai Municipal Education Commission, Shanghai Science and Technology Committee Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactive oxygen species (ROS) play a crucial role in orchestrating a myriad of physiological processes within living systems. With the advent of materdicine, an array of nanomaterials has been intricately engineered to influence the redox equilibrium in biological milieus, thereby pioneering a distinctive therapeutic paradigm predicated on ROS‐centric biochemistry. Among these, two‐dimensional carbides, nitrides, and carbonitrides, collectively known as MXenes, stand out due to their multi‐valent and multi‐elemental compositions, large surface area, high conductivity, and pronounced local surface plasmon resonance effects, positioning them as prominent contributors in ROS modulation. This review aims to provide an overview of the advancements in harnessing MXenes for catalytic redox reactions in various biological applications, including tumor, anti‐infective, and anti‐inflammatory therapies. The emphasis lies on elucidating the therapeutic mechanism of MXenes, involving both pro‐oxidation and anti‐oxidation processes, underscoring the redox‐related therapeutic applications facilitated by self‐catalysis, photo‐excitation, and sono‐excitation properties of MXenes. Furthermore, this review highlights the existing challenges and outlines future development trends in leveraging MXenes for ROS‐involving disease treatments, marking a significant step towards the integration of these nanomaterials into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidation-ReductionCatalysisHumansReactive Oxygen SpeciesNanostructuresAnti-Infective AgentsAntineoplastic AgentsAnti-Inflammatory Agents

Stichwörter der Autor:innen

MXenecatalytic biomaterialsnanomedicinereactive oxygen speciesredox regulation

Substanzen

Reactive Oxygen SpeciesAnti-Infective AgentsAntineoplastic AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, China.
  • Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute of Shanghai University, Zhejiang, 325088, China.

ORCID-Profile: Yu Chen

Förderung

  • National Natural Science Foundation of China
  • Shanghai Education Development Foundation and Shanghai Municipal Education Commission
  • Shanghai Science and Technology Committee Rising-Star Program
  • Shanghai Science and Technology Committee Biomedical Program
  • Key Science and Technology Research and Development Projects of Jiangxi Province
  • Wenzhou Basic Scientific Research Project
  • Postdoctoral Fellowship Program of CPSF

Zitieren

APA

Wu, C., Xia, L., Feng, W., & Chen, Y. (2024). MXene‐Mediated Catalytic Redox Reactions for Biomedical Applications. ChemPlusChem. https://doi.org/10.1002/cplu.202300777

Vancouver

Wu C, Xia L, Feng W, Chen Y. MXene‐Mediated Catalytic Redox Reactions for Biomedical Applications. ChemPlusChem. 2024. doi:10.1002/cplu.202300777

BibTeX
@article{Wu2024,
  author = {Wu, Chenyao and Xia, Lili and Feng, Wei and Chen, Yu},
  title = {MXene‐Mediated Catalytic Redox Reactions for Biomedical Applications},
  journal = {ChemPlusChem},
  year = {2024},
  doi = {10.1002/cplu.202300777}
}
Kostenlos starten →